.@ersgenomics today announced the signing of a #license agreement with Otsuka Pharmaceutical Co. Ltd.

The agreement grants access to ERS' #CRISPRCas9 genome editing technology for #research and development.

Read more:

.@Dotmatics today announced a licensing agreement with @CompugenInc to supply #informatics technology. The Company's #LIMS and #ELN were chosen to support Compugen's #drugdiscovery and marks Dotmatics' first implementation in Israel. Read more:

.@OXGENEofficial has announced it has been acquired by @WuXi_AppTec and will operate as part of its @Adv_Therapies, becoming its first European facility.

The acquisition supports the #RandD of cell and #gene #therapies for patients in need worldwide:

.@CN_Bio today announced it has been awarded an @innovateuk grant to develop single and multi-organ models for #COVID19 research.

The funding will advance 3D lung #cellculture models to accelerate #drugdiscovery

Read more:

.@ersgenomics today announced the #appointment of Jon Kratochvil as Vice-President for Business Development & #Licensing for North America.

Read more:

Load More